Activity of the antioxidant enzyme paraoxonase in Argentinean children living at high altitude

Redox Rep. 2018 Dec;23(1):35-40. doi: 10.1080/13510002.2017.1370783. Epub 2017 Aug 30.

Abstract

Background: Children living at high altitude in San Antonio de los Cobres (SAC), Argentina, were shown to have lower high-density lipoprotein cholesterol (HDL-C) levels than Buenos Aires (BA) children. HDL antioxidant capacity is mainly attributed to paraoxonase1 (PON1).

Objective: To compare PON1 activity in indigenous SAC vs. BA children.

Methods: A cross-sectional study compared 158 SAC vs. 97 BA children (6-16 years). Anthropometric data and lipoprotein profile were measured. PON1 was evaluated employing paraoxon (PON) and phenylacetate (ARE) activity.

Results: The prevalence of overweight/obesity was lower in SAC than in BA children (18.3 vs. 30.9%). Triglycerides (1.34 vs. 0.90 mmol/l), apo B (0.84 vs.0.72 g/l), apo A-I (1.33 vs. 1.27 g/l), and ARE activity (100 vs. 90 µmol/ml/min) were higher, while HDL-C (1.16 vs. 1.32 mmol/l) and PON activity (170 vs. 203 nmol/ml/min) were lower in SAC than in BA. Separate multiple linear regression analyses showed that SAC children had significantly higher triglyceride (Beta -0.38), apo B (Beta -0.34), and ARE (Beta -0.36) plus lower HDL-C (Beta 0.33) and PON (Beta 0.25) compared with BA; adjusted for age, gender, and BMI.

Conclusion: SAC showed an unfavorable lipoprotein profile, lower PON and higher ARE activities compared with BA children, suggesting the presence of altered HDL metabolism and antioxidant capacity.

Keywords: HDL; High altitude; PON1; atherosclerosis; indigenous school children.

MeSH terms

  • Adolescent
  • Altitude
  • Apolipoprotein A-I / blood
  • Argentina / epidemiology
  • Argentina / ethnology
  • Aryldialkylphosphatase / blood*
  • Aryldialkylphosphatase / genetics
  • Aryldialkylphosphatase / metabolism
  • Child
  • Cholesterol, HDL / blood
  • Cross-Sectional Studies
  • Female
  • Humans
  • Linear Models
  • Lipids / blood
  • Male
  • Pediatric Obesity / enzymology*
  • Pediatric Obesity / epidemiology
  • Phenylacetates / metabolism
  • Risk Factors
  • Triglycerides / blood

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Lipids
  • Phenylacetates
  • Triglycerides
  • Aryldialkylphosphatase
  • PON1 protein, human
  • phenylacetic acid